aspirin and prevention of cognitive decline in postmenopausal women
Last reviewed 11/2023
- the use of low dose aspirin as a measure to prevent cognitive decline
in postmenopausal women has been investigated in the Women's Health Study
- cohort study within both arms of the women's health study, a randomised, double blind, placebo controlled trial
- 6377 women aged 65 or more were given low dose aspirin (100 mg on alternate days) or placebo for a mean of 9.6 years
- the study authors concluded that the evidence did not support the use of low dose aspirin in postmenopausal women to prevent cognitive decline
Reference: